Tolebrutinib is an oral, brain-penetrant, and bioactive Bruton’s tyrosine kinase inhibitor that modulates peripheral ...

Autoimmune generalized myasthenia gravis is a disease that manifests with fluctuating muscle weakness. Inebilizumab is a ...

Throughout the course of multiple sclerosis, gradually progressive neurologic impairment can occur, which has been called ...

Giant-cell arteritis is a systemic vasculitis with limited treatment options. The efficacy and safety of upadacitinib — a ...

The National Academy of Medicine convened a workshop of experts and published a report that reviews the progress generative AI has achieved in health care and discusses future opportunities and ...

The incidence of prostate cancer is increasing. Screening with an assay of prostate-specific antigen (PSA) has a high rate for false positive results. Genomewide association studies have ...

Is the incidence of acute otitis media increasing or decreasing in the United States? Although the incidence of acute otitis media, and particularly of recurrent and refractory cases, has been ...

The New England Journal of Medicine is committed to responsible data sharing in the setting of clinical trials. To encourage an open discussion, the collection below explores diverse viewpoints ...

The effects and risks of the use of intravenous thrombolysis between 4.5 and 24 hours after the onset of a posterior circulation ischemic stroke are not well studied. In a trial conducted in China ...